Pegaspargase

In the US, Pegaspargase (pegaspargase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX24

CAS registry number (Chemical Abstracts Service)

0130167-69-0

Therapeutic Category

Antineoplastic agent

Chemical Names

Asparaginase, reaction product with succinic anhydride, esters with polyethylene glycol monomethyl ether

Poly{N-[alpha-methyl-omega-succinylpoly(oxyethylen)oxy]}sparaginase

Foreign Names

  • Pegaspargasum (Latin)
  • Pegaspargase (German)
  • Pegaspargase (French)
  • Pegaspargasa (Spanish)

Generic Names

  • Pegaspargase (OS: USAN)
  • PEG-L-asparaginase (IS)

Brand Names

  • Oncaspar
    Enzon, United States; Filaxis, Argentina; medac, Germany; medac, Poland

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web2)